A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

even during cancer treatment. Scientists also revealed that circular fragments of DNA called extrachromosomal DNA (ecDNA) is ...

Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

Her oncologist, Ramy Sedhom, MD, suggested she take oxybutynin, an inexpensive drug for overactive bladder that has been ...

New report outlines long-term risks of prostate cancer treatment, highlighting potential impacts on quality of life and need ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years ...

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

Though they may seem like something from the future, these five cancer vaccines are available now. Here are details about who ...

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.